FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

SRYBNIK SIMON 		2. Issuer Name and Ticker or Trading Symbol

VASOMEDICAL, INC [ VASO.PK ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O VASOMEDICAL, INC., 137 COMMERCIAL STREET, SUITE 200 		3. Date of Earliest Transaction (MM/DD/YYYY)

7/5/2016
(Street)

PLAINVIEW, NY 11803
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  17815007   I   By Living Data Technology Corporation   (1)
Common Stock                  12059025   (3) D    
Common Stock                  25714286   (4) I   By Kerns Manufacturing Corp.   (2)
Common Stock   7/5/2016     A    150000   A   (5) 12209.025   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2004 Stock Option/Stock Issuance Plan   $.12                      (6) 7/25/2017   Common Stock   150000     150000   D    

Explanation of Responses:
( 1)  The reporting person and the Estate of his brother Louis Srybnik each own 35% of the outstanding shares of Living Data Technology Corp. The reporting person, accordingly, shares with the Estate of his brother voting and dispositive powers over these shares and, as a result, may be deemed to be the co-beneficial owner thereof.
( 2)  The reporting person and the Estate of his brother Louis Srybnik are the sole shareholders of Kerns Manufacturing Corp., each owning 50% of the shares. The reporting person, accordingly, shares with the Estate of his brother voting and dispositive powers over the shares and, as a result, may be deemed to be the co-beneficial owner thereof.
( 3)  Includes 11,460,900 shares issued upon conversion of Series E Convertible Preferred Stock.
( 4)  4,285,714 shares represent common stock issued upon exercise of Warrant issued on June 21, 2007 to Kerns Manufacturing Corp.
( 5)  Restricted shares of which 50,000 vest immediately with the remaining shares contingently vesting as follows: 50,000 on July 5, 2017 and 50,000 on July 5, 2018.
( 6)  Options vest immediately.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SRYBNIK SIMON
C/O VASOMEDICAL, INC.
137 COMMERCIAL STREET, SUITE 200
PLAINVIEW, NY 11803 		X X


Signatures
/s/ Simon Srybnik 7/5/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Vaso (QX) (USOTC:VASO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Vaso (QX) Charts.
Vaso (QX) (USOTC:VASO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Vaso (QX) Charts.